Golden State Equity Partners »

Centessa Pharmaceuticals shares owned by Golden State Equity Partners

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by Golden State Equity Partners from 13F filings

Historical chart of Golden State Equity Partners investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by Golden State Equity Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by Golden State Equity Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $27k 1.7k 15.99
2022-03-31 $143k 16k 8.95
2021-12-31 $156k 14k 11.25

More positions owned by Golden State Equity Partners

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Harbor Etf Trust Long Term Grower (WINN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Harbor Etf Trust Long Term Grower (WINN)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
First Tr Exchange-traded Smid Risng Etf (SDVY)
First Tr Exch Traded Fd Iii Horizon Dmst Etf (HUSV)
salesforce (CRM)

View all positions for Golden State Equity Partners

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
General Atlantic
Perceptive Advisors
First Light Asset Management
EcoR1 Capital
T. Rowe Price Associates
Vida Ventures Advisors
T. Rowe Price Investment Management
Siren
TCG Crossover Management
Point72 Asset Management
Franklin Resources
Driehaus Capital Management
Avidity Partners Management
Morgan Stanley

View all funds holding Centessa Pharmaceuticals